Eli Lilly & Co. (LLY)
1023.22
+2.66
(+0.26%)
USD |
NYSE |
Feb 19, 16:00
1023.51
+0.29
(+0.03%)
Pre-Market: 05:58
Eli Lilly Research and Development Expense (Quarterly) : 3.802B for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 2.151B |
| Biogen, Inc. | 434.00M |
| Regeneron Pharmaceuticals, Inc. | 1.481B |
| Viking Therapeutics, Inc. | 153.46M |
| Moderna, Inc. | 775.00M |